Warning to women amid shortages of some HRT products

Warning to women amid shortages of some HRT products

Dr Ursula Mason, who leads the Royal College of General Practitioners in Northern Ireland, highlighted the distress patients may feel when asked to switch their prescribed medications. She emphasized that this anxiety is especially prevalent among women using hormone replacement therapy (HRT), particularly when they have identified a specific formulation that suits them well. To reassure patients, Dr Mason explained that any substitution must involve an identical active ingredient and dosage.

She advised that if women experience issues such as side effects or ongoing symptoms after changing their HRT medication, they should promptly consult their GP. Discussing symptoms and exploring alternative options with a healthcare professional is crucial to managing their treatment effectively.

The Department of Health has acknowledged widespread supply challenges impacting certain HRT products across the United Kingdom. In particular, there have been prolonged shortages of Estradot transdermal patches, and more recently, FemSeven Conti patches have faced availability problems. The department has communicated guidance to healthcare providers, including recommendations for suitable alternative treatments.

Under the current Serious Shortage Protocols (SSPs) in place until January 8, 2027, pharmacists are allowed to dispense substitute products without requiring a new prescription, provided the patient consents. The department encourages patients experiencing difficulty obtaining their prescribed HRT or concerns about alternatives to seek advice from their healthcare professionals.

Roisin Hillman, co-founder of Menopause Together—the first menopause support charity in Northern Ireland—expressed frustration over the ongoing shortage of HRT patches. She explained that many women who have been forced to switch brands report side effects such as itching or the patches failing to adhere properly. Hillman described the problem as persistent, urging women to request longer prescriptions from their GPs to mitigate supply interruptions.

She also cautioned against sharing HRT medication with others, stressing that what works for one woman might not be suitable for another. Hillman urged those unable to obtain their usual medication to consult their doctor rather than turning to others’ prescriptions. She recognized that losing access to the right HRT can significantly impact a woman’s well-being, particularly affecting mental health, and acknowledged the fear and anxiety this situation can cause

Read the full article from The BBC here: Read More